相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Robert Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Prognostic and Clinicopathological Value of Human Leukocyte Antigen G in Gastrointestinal Cancers: A Meta-Analysis
Yongjia Peng et al.
FRONTIERS IN ONCOLOGY (2021)
Cytometry-based analysis of HLA-G functions according to ILT2 expression
A. Jacquier et al.
HUMAN IMMUNOLOGY (2020)
CD8+PD-1-ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G
Clement Dumont et al.
CANCER IMMUNOLOGY RESEARCH (2019)
The Emerging Landscape of p53 Isoforms in Physiology, Cancer and Degenerative Diseases
Thineskrishna Anbarasan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The SLAM family receptors: Potential therapeutic targets for inflammatory and autoimmune diseases
Matthew A. Dragovich et al.
AUTOIMMUNITY REVIEWS (2018)
HLA-G peptide preferences change in transformed cells: impact on the binding motif
Alexander A. Celik et al.
IMMUNOGENETICS (2018)
Next generation of immune checkpoint therapy in cancer: new developments and challenges
Julian A. Marin-Acevedo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
Aifen Lin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Clinical Significance of Potential Unidentified HLA-G Isoforms Without α1 Domain but Containing Intron 4 in Colorectal Cancer Patients
Aifen Lin et al.
FRONTIERS IN ONCOLOGY (2018)
Cutting Edge: Class II-like Structural Features and Strong Receptor Binding of the Nonclassical HLA-G2 Isoform Homodimer
Kimiko Kuroki et al.
JOURNAL OF IMMUNOLOGY (2017)
Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients
Diana Tronik-Le Roux et al.
MOLECULAR ONCOLOGY (2017)
Inhibition of T Cell Alloreactivity by Bronchial Epithelium Is Impaired in Lung Transplant Recipients, Through Pathways Involving TGF-, IL-10 and HLA-G
Clairelyne Dupin et al.
TRANSPLANTATION (2017)
Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4
Nathalie Rouas-Freiss et al.
ONCOIMMUNOLOGY (2017)
Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue Maintain Their Immunosuppressive Properties After Chondrogenic Differentiation: Role of HLA-G
Wen-Jing Du et al.
STEM CELLS AND DEVELOPMENT (2016)
A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G
Edgardo D. Carosella et al.
EUROPEAN UROLOGY (2015)
HLA-G: An Immune Checkpoint Molecule
Edgardo D. Carosella et al.
ADVANCES IN IMMUNOLOGY, VOL 127 (2015)
HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: The influence of the tumor microenvironment
Sonia Zilberman et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
KIR2DL4 (CD158d). an activation receptor for HLA-G
Sumati Rajagopalan et al.
FRONTIERS IN IMMUNOLOGY (2012)
The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells
Roberta Rizzo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Inhibition of human Vγ9Vδ2 T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer
Emilie Lesport et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells
Changlin Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer
M Shiroishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes
R Bahri et al.
JOURNAL OF IMMUNOLOGY (2006)
The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and β2-microglobulin-free HLA-G molecules
T Gonen-Gross et al.
JOURNAL OF IMMUNOLOGY (2005)
Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function
T Gonen-Gross et al.
JOURNAL OF IMMUNOLOGY (2003)
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G
M Shiroishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
HLA-G2,-G3, and-G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis
B Riteau et al.
JOURNAL OF IMMUNOLOGY (2001)
HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition
B Riteau et al.
INTERNATIONAL IMMUNOLOGY (2001)
分享论文
